Cargando…
Lack of timely accrual information in oncology clinical trials: a cross-sectional analysis
BACKGROUND: Poor accrual is a significant barrier to the successful completion of oncology clinical trials; half of all phase 3 oncology trials close due to insufficient accrual. Timely access to accrual data fosters an understanding of successful trial design and can be used to inform the design of...
Autores principales: | Mitchell, Aaron P, Hirsch, Bradford R, Abernethy, Amy P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987844/ https://www.ncbi.nlm.nih.gov/pubmed/24661848 http://dx.doi.org/10.1186/1745-6215-15-92 |
Ejemplares similares
-
Accrual in supportive care trials in pediatric oncology, a challenge!
por: Schoot, R. A., et al.
Publicado: (2012) -
Trial-level factors affecting accrual and completion of oncology clinical trials: A systematic review
por: Hauck, Cherie L., et al.
Publicado: (2021) -
Clinical Trial Accrual: Obstacles and Opportunities
por: Rimel, B. J.
Publicado: (2016) -
Accrual monitoring in cardiovascular trials
por: Baldi, Ileana, et al.
Publicado: (2017) -
Promoting Accrual of Older Patients with Cancer to Clinical Trials: An Alliance for Clinical Trials in Oncology Member Survey (A171602)
por: Freedman, Rachel A., et al.
Publicado: (2018)